Maryland (Physicians Realty Trust) Delaware (Physicians Realty L.P.) (State or other jurisdiction of incorporation or organization) | 001-36007 333-205034-01 (Commission File Number) | 46-2519850 80-0941870 (I.R.S. Employer Identification No.) |
309 N. Water Street, Suite 500 Milwaukee, Wisconsin (Address of principal executive offices) | 53202 (Zip Code) |
Date: September 8, 2017 | PHYSICIANS REALTY TRUST | |
By: | /s/ John T. Thomas | |
John T. Thomas | ||
President and Chief Executive Officer | ||
Date: September 8, 2017 | PHYSICIANS REALTY L.P. | |
by: Physicians Realty Trust, its general partner | ||
By: | /s/ John T. Thomas | |
John T. Thomas | ||
President and Chief Executive Officer |
Three Months Ended March 31, 2017 | Year Ended December 31, 2016 | ||||||
(unaudited) | |||||||
Rental revenues | $ | 3,235 | $ | 12,941 | |||
Other revenues | 166 | 503 | |||||
Expense recoveries | 1,844 | 7,326 | |||||
Total revenues | 5,245 | 20,770 | |||||
Operating expenses | (1,878 | ) | (7,461 | ) | |||
Revenues in excess of operating expenses | $ | 3,367 | $ | 13,309 |
2017 | $ | 12,515,560 | ||
2018 | 12,807,088 | |||
2019 | 13,104,614 | |||
2020 | 13,409,847 | |||
2021 | 13,596,018 | |||
Thereafter | 60,417,857 | |||
Total | $ | 125,850,984 |
Historical | July 2017 Offering | Baylor Cancer Center | Pro Forma Reflecting Acquisition | |||||||||||||
ASSETS | ||||||||||||||||
Investment properties: | ||||||||||||||||
Land and improvements | $ | 201,372 | $ | — | $ | — | $ | 201,372 | ||||||||
Building and improvements | 2,577,895 | — | 256,652 | 2,834,547 | ||||||||||||
Tenant improvements | 15,646 | — | 234 | 15,880 | ||||||||||||
Acquired lease intangibles | 341,417 | — | 33,795 | 375,212 | ||||||||||||
3,136,330 | — | 290,681 | 3,427,011 | |||||||||||||
Accumulated depreciation | (204,516 | ) | — | — | (204,516 | ) | ||||||||||
Net real estate property | 2,931,814 | — | 290,681 | 3,222,495 | ||||||||||||
Real estate held for sale | 11,926 | — | 11,926 | |||||||||||||
Real estate loans receivable | 40,258 | — | — | 40,258 | ||||||||||||
Investment in unconsolidated entities | 2,231 | — | — | 2,231 | ||||||||||||
Net real estate investments | 2,986,229 | — | 290,681 | 3,276,910 | ||||||||||||
Cash and cash equivalents | 117,484 | 421,051 | (290,000 | ) | 248,535 | |||||||||||
Tenant receivables, net | 6,882 | — | — | 6,882 | ||||||||||||
Other assets | 85,798 | — | — | 85,798 | ||||||||||||
Total assets | $ | 3,196,393 | $ | 421,051 | $ | 681 | $ | 3,618,125 | ||||||||
LIABILITIES AND EQUITY | ||||||||||||||||
Liabilities: | ||||||||||||||||
Credit facility | $ | 243,163 | $ | — | $ | — | $ | 243,163 | ||||||||
Notes payable | 619,972 | — | — | 619,972 | ||||||||||||
Mortgage debt | 143,543 | — | — | 143,543 | ||||||||||||
Accounts payable | 3,126 | — | — | 3,126 | ||||||||||||
Dividends and distributions payable | 36,485 | — | — | 36,485 | ||||||||||||
Accrued expenses and other liabilities | 36,206 | — | — | 36,206 | ||||||||||||
Acquired lease intangibles, net | 9,433 | — | 681 | 10,114 | ||||||||||||
Total liabilities | 1,091,928 | — | 681 | 1,092,609 | ||||||||||||
Redeemable noncontrolling interest - partially owned properties | 11,931 | — | — | 11,931 | ||||||||||||
Equity: | ||||||||||||||||
Total shareholders' equity | 2,020,843 | 421,051 | — | 2,441,894 | ||||||||||||
Total noncontrolling interests | 71,691 | — | — | 71,691 | ||||||||||||
Total equity | 2,092,534 | 421,051 | — | 2,513,585 | ||||||||||||
Total liabilities and equity | $ | 3,196,393 | $ | 421,051 | $ | 681 | $ | 3,618,125 |
Historical | July 2017 Offering | Baylor Cancer Center | Pro Forma Reflecting Acquisition | |||||||||||||
ASSETS | ||||||||||||||||
Investment properties: | ||||||||||||||||
Land and improvements | $ | 201,372 | $ | — | $ | — | $ | 201,372 | ||||||||
Building and improvements | 2,577,895 | — | 256,652 | 2,834,547 | ||||||||||||
Tenant improvements | 15,646 | — | 234 | 15,880 | ||||||||||||
Acquired lease intangibles | 341,417 | — | 33,795 | 375,212 | ||||||||||||
3,136,330 | — | 290,681 | 3,427,011 | |||||||||||||
Accumulated depreciation | (204,516 | ) | — | — | (204,516 | ) | ||||||||||
Net real estate property | 2,931,814 | — | 290,681 | 3,222,495 | ||||||||||||
Real estate held for sale | 11,926 | — | — | 11,926 | ||||||||||||
Real estate loans receivable | 40,258 | — | — | 40,258 | ||||||||||||
Investment in unconsolidated entities | 2,231 | — | — | 2,231 | ||||||||||||
Net real estate investments | 2,986,229 | — | 290,681 | 3,276,910 | ||||||||||||
Cash and cash equivalents | 117,484 | 421,051 | (290,000 | ) | 248,535 | |||||||||||
Tenant receivables, net | 6,882 | — | — | 6,882 | ||||||||||||
Other assets | 85,798 | — | — | 85,798 | ||||||||||||
Total assets | $ | 3,196,393 | $ | 421,051 | $ | 681 | $ | 3,618,125 | ||||||||
LIABILITIES AND CAPITAL | ||||||||||||||||
Liabilities: | ||||||||||||||||
Credit facility | $ | 243,163 | $ | — | $ | — | $ | 243,163 | ||||||||
Notes payable | 619,972 | — | — | 619,972 | ||||||||||||
Mortgage debt | 143,543 | — | — | 143,543 | ||||||||||||
Accounts payable | 3,126 | — | — | 3,126 | ||||||||||||
Dividends and distributions payable | 36,485 | — | — | 36,485 | ||||||||||||
Accrued expenses and other liabilities | 36,206 | — | — | 36,206 | ||||||||||||
Acquired lease intangibles, net | 9,433 | — | 681 | 10,114 | ||||||||||||
Total liabilities | 1,091,928 | — | 681 | 1,092,609 | ||||||||||||
Redeemable noncontrolling interest - partially owned properties | 11,931 | — | — | 11,931 | ||||||||||||
Capital: | ||||||||||||||||
Total partners' capital | 2,091,886 | 421,051 | — | 2,512,937 | ||||||||||||
Total noncontrolling interests - partially owned properties | 648 | — | — | 648 | ||||||||||||
Total capital | 2,092,534 | 421,051 | — | 2,513,585 | ||||||||||||
Total liabilities and capital | $ | 3,196,393 | $ | 421,051 | $ | 681 | $ | 3,618,125 |
Historical | July 2017 Offering | Baylor Cancer Center | Pro Forma Reflecting Acquisition | |||||||||||||
Revenues: | ||||||||||||||||
Rental revenues | $ | 59,092 | $ | — | $ | 3,235 | $ | 62,327 | ||||||||
Expense recoveries | 16,354 | — | 1,844 | 18,198 | ||||||||||||
Interest income on real estate loans and other | 1,220 | — | 166 | 1,386 | ||||||||||||
Total revenues | 76,666 | — | 5,245 | 81,911 | ||||||||||||
Expenses: | ||||||||||||||||
Interest expense | 9,815 | — | — | 9,815 | ||||||||||||
General and administrative | 4,736 | — | — | 4,736 | ||||||||||||
Operating expenses | 22,089 | — | 1,878 | 23,967 | ||||||||||||
Depreciation and amortization | 27,933 | — | 2,379 | 30,312 | ||||||||||||
Acquisition expenses | 5,405 | — | 641 | 6,046 | ||||||||||||
Total expenses | 69,978 | — | 4,898 | 74,876 | ||||||||||||
Income before equity in income of unconsolidated entities: | 6,688 | — | 347 | 7,035 | ||||||||||||
Equity in income of unconsolidated entities | 28 | — | — | 28 | ||||||||||||
Net income | 6,716 | — | 347 | 7,063 | ||||||||||||
Net income attributable to noncontrolling interests | ||||||||||||||||
Operating Partnership | (147 | ) | — | (8 | ) | (155 | ) | |||||||||
Partially owned properties | (167 | ) | — | — | (167 | ) | ||||||||||
Net income attributable to controlling interests | 6,402 | — | 339 | 6,741 | ||||||||||||
Preferred distributions | (211 | ) | — | — | (211 | ) | ||||||||||
Net income attributable to common shareholders | $ | 6,191 | $ | — | $ | 339 | $ | 6,530 | ||||||||
Net income per share: | ||||||||||||||||
Basic | $ | 0.04 | $ | 0.04 | ||||||||||||
Diluted | $ | 0.04 | $ | 0.04 | ||||||||||||
Weighted average common shares: | ||||||||||||||||
Basic | 138,986,629 | 21,500,000 | 160,486,629 | |||||||||||||
Diluted | 142,605,930 | 21,500,000 | 164,105,930 |
Historical | July 2017 Offering | Baylor Cancer Center | 2016 Acquisition Properties | Pro Forma Reflecting Acquisitions | ||||||||||||||||
Revenues: | ||||||||||||||||||||
Rental revenues | $ | 186,301 | $ | — | $ | 12,941 | $ | 23,142 | $ | 222,384 | ||||||||||
Expense recoveries | 45,875 | — | 7,326 | 8,028 | 61,229 | |||||||||||||||
Interest income on real estate loans and other | 8,858 | — | 503 | 26 | 9,387 | |||||||||||||||
Total revenues | 241,034 | — | 20,770 | 31,196 | 293,000 | |||||||||||||||
Expenses: | ||||||||||||||||||||
Interest expense | 23,864 | — | — | 2,952 | 26,816 | |||||||||||||||
General and administrative | 18,397 | — | — | — | 18,397 | |||||||||||||||
Operating expenses | 65,999 | — | 7,461 | 10,869 | 84,329 | |||||||||||||||
Depreciation and amortization | 86,589 | — | 9,516 | 10,626 | 106,731 | |||||||||||||||
Acquisition expenses | 14,778 | — | 641 | — | 15,419 | |||||||||||||||
Total expenses | 209,627 | — | 17,618 | 24,447 | 251,692 | |||||||||||||||
Income before equity in income of unconsolidated entities: | 31,407 | — | 3,152 | 6,749 | 41,308 | |||||||||||||||
Equity in income of unconsolidated entities | 115 | — | — | — | 115 | |||||||||||||||
Net income | 31,522 | — | 3,152 | 6,749 | 41,423 | |||||||||||||||
Net income attributable to noncontrolling interests: | ||||||||||||||||||||
Operating Partnership | (825 | ) | — | (82 | ) | (177 | ) | (1,084 | ) | |||||||||||
Partially owned properties | (716 | ) | — | — | — | (716 | ) | |||||||||||||
Net income attributable to controlling interest | 29,981 | — | 3,070 | 6,572 | 39,623 | |||||||||||||||
Preferred distributions | (1,857 | ) | — | — | — | (1,857 | ) | |||||||||||||
Net income attributable to common shareholders | $ | 28,124 | $ | — | $ | 3,070 | $ | 6,572 | $ | 37,766 | ||||||||||
Net income per share: | ||||||||||||||||||||
Basic | $ | 0.22 | $ | 0.24 | ||||||||||||||||
Diluted | $ | 0.22 | $ | 0.24 | ||||||||||||||||
Weighted average common shares: | ||||||||||||||||||||
Basic | 126,143,114 | 21,500,000 | 7,140,369 | 154,783,483 | ||||||||||||||||
Diluted | 130,466,893 | 21,500,000 | 7,140,369 | 159,107,262 |
Historical | July 2017 Offering | Baylor Cancer Center | Pro Forma Reflecting Acquisition | |||||||||||||
Revenues: | ||||||||||||||||
Rental revenues | $ | 59,092 | $ | — | $ | 3,235 | $ | 62,327 | ||||||||
Expense recoveries | 16,354 | — | 1,844 | 18,198 | ||||||||||||
Interest income on real estate loans and other | 1,220 | — | 166 | 1,386 | ||||||||||||
Total revenues | 76,666 | — | 5,245 | 81,911 | ||||||||||||
Expenses: | ||||||||||||||||
Interest expense | 9,815 | — | — | 9,815 | ||||||||||||
General and administrative | 4,736 | — | — | 4,736 | ||||||||||||
Operating expenses | 22,089 | — | 1,878 | 23,967 | ||||||||||||
Depreciation and amortization | 27,933 | — | 2,379 | 30,312 | ||||||||||||
Acquisition expenses | 5,405 | — | 641 | 6,046 | ||||||||||||
Total expenses | 69,978 | — | 4,898 | 74,876 | ||||||||||||
Income before equity in income of unconsolidated entities: | 6,688 | — | 347 | 7,035 | ||||||||||||
Equity in income of unconsolidated entities | 28 | — | — | 28 | ||||||||||||
Net income | 6,716 | — | 347 | 7,063 | ||||||||||||
Net income attributable to noncontrolling interests - partially owned properties | (167 | ) | — | — | (167 | ) | ||||||||||
Net income attributable to controlling interest | 6,549 | — | 347 | 6,896 | ||||||||||||
Preferred distributions | (211 | ) | — | — | (211 | ) | ||||||||||
Net income attributable to common unitholders | $ | 6,338 | $ | — | $ | 347 | $ | 6,685 | ||||||||
Net income per common unit: | ||||||||||||||||
Basic | $ | 0.04 | $ | 0.04 | ||||||||||||
Diluted | $ | 0.04 | $ | 0.04 | ||||||||||||
Weighted average common units: | ||||||||||||||||
Basic | 142,172,746 | 21,500,000 | 163,672,746 | |||||||||||||
Diluted | 142,605,930 | 21,500,000 | 164,105,930 |
Historical | July 2017 Offering | Baylor Cancer Center | 2016 Acquisition Properties | Pro Forma Reflecting Acquisitions | ||||||||||||||||
Revenues: | ||||||||||||||||||||
Rental revenues | $ | 186,301 | $ | — | $ | 12,941 | $ | 23,142 | $ | 222,384 | ||||||||||
Expense recoveries | 45,875 | — | 7,326 | 8,028 | 61,229 | |||||||||||||||
Interest income on real estate loans and other | 8,858 | — | 503 | 26 | 9,387 | |||||||||||||||
Total revenues | 241,034 | — | 20,770 | 31,196 | 293,000 | |||||||||||||||
Expenses: | ||||||||||||||||||||
Interest expense | 23,864 | — | — | 2,952 | 26,816 | |||||||||||||||
General and administrative | 18,397 | — | — | — | 18,397 | |||||||||||||||
Operating expenses | 65,999 | — | 7,461 | 10,869 | 84,329 | |||||||||||||||
Depreciation and amortization | 86,589 | — | 9,516 | 10,626 | 106,731 | |||||||||||||||
Acquisition expenses | 14,778 | — | 641 | — | 15,419 | |||||||||||||||
Total expenses | 209,627 | — | 17,618 | 24,447 | 251,692 | |||||||||||||||
Income before equity in income of unconsolidated entities: | 31,407 | — | 3,152 | 6,749 | 41,308 | |||||||||||||||
Equity in income of unconsolidated entities | 115 | — | — | — | 115 | |||||||||||||||
Net income | 31,522 | — | 3,152 | 6,749 | 41,423 | |||||||||||||||
Net income attributable to noncontrolling interests - partially owned properties | (716 | ) | — | — | — | (716 | ) | |||||||||||||
Net income attributable to controlling interest | 30,806 | — | 3,152 | 6,749 | 40,707 | |||||||||||||||
Preferred distributions | (1,857 | ) | — | — | — | (1,857 | ) | |||||||||||||
Net income attributable to common unitholders | $ | 28,949 | $ | — | $ | 3,152 | $ | 6,749 | $ | 38,850 | ||||||||||
Net income per common unit: | ||||||||||||||||||||
Basic | $ | 0.22 | $ | 0.25 | ||||||||||||||||
Diluted | $ | 0.22 | $ | 0.24 | ||||||||||||||||
Weighted average common units: | ||||||||||||||||||||
Basic | 129,835,209 | 21,500,000 | 7,140,369 | 158,475,578 | ||||||||||||||||
Diluted | 130,466,893 | 21,500,000 | 7,140,369 | 159,107,262 |